LogiCare3PL Selected as Distribution Partner by Harrow

Harrow (Nasdaq: HROW) has selected LogiCare3PL as its U.S. distribution partner for Harrow's ophthalmic disease management solutions.

Rhea-AI Summary

Harrow (Nasdaq: HROW) has selected LogiCare3PL as its U.S. distribution partner for Harrow's ophthalmic disease management solutions. Effective Feb 1, 2026, LogiCare3PL will provide both non-title logistics and 3PL title distribution across the U.S., meeting Harrow's rapid onboarding needs.

LogiCare3PL completed Harrow's onboarding in four weeks, supporting faster, cost-effective market access while maintaining high-touch customer engagement and continuity of supply.

Positive

• Agreement effective Feb 1, 2026
• Onboarded Harrow in 4 weeks, meeting implementation timeline
• Provides both non-title and 3PL title distribution services
• Supports U.S. nationwide market access for Harrow products

Negative

• None.

Argus Apr 14 session

+2.16% close to close Open Argus

Details

News Market Reaction – HROW

In the Apr 14 session, HROW gained 2.16%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details Harrow’s selection of LogiCare3PL as a U.S. distribution partner effective...

Analysis

This announcement details Harrow’s selection of LogiCare3PL as a U.S. distribution partner effective February 1, 2026, covering non-title logistics and full 3PL title services. It fits alongside recent financing and clinical initiatives, emphasizing commercialization readiness for an ophthalmic portfolio. Investors may focus on how this partnership affects product availability, onboarding speed—already demonstrated within four weeks—and support for future product launches, while tracking subsequent disclosures on sales trends and operational performance.

Key Figures

Partnership effective date: February 1, 2026 Onboarding timeline: four weeks

Partnership effective date

February 1, 2026

Start of LogiCare3PL distribution services for Harrow’s products

Onboarding timeline

four weeks

Time LogiCare3PL took to onboard Harrow and ensure continuity

Historical Context

5 past events · Latest: Mar 24

5 events

1. Mar 24

   Debt financing

   24h Move

   +3.3%

   Priced $50M add-on of 8.625% 2030 notes for general corporate purposes.

2. Mar 24

   Debt financing

   24h Move

   +3.5%

   Announced intent for $50M additional 2030 notes to support growth initiatives.

3. Mar 18

   Scientific meeting

   24h Move

   -2.1%

   Three ASCRS 2026 abstracts accepted featuring VEVYE and ILEVRO product data.

4. Mar 04

   Conference appearance

   24h Move

   +1.6%

   Planned presentation at Leerink Partners 2026 Global Healthcare Conference.

5. Mar 03

   Clinical trial

   24h Move

   -28.0%

   FDA-cleared IND for Phase 3 TRIESENCE trial in post-cataract inflammation and pain.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ophthalmic, 3pl

2 terms

ophthalmic medical

"Harrow's portfolio of ophthalmic disease management solutions."

Relating to the eye and its care, including medicines, drops, diagnostic tools and surgical devices used to prevent, diagnose or treat eye conditions. Investors care because ophthalmic products form a distinct market with specialized safety approvals, manufacturing needs and payer coverage, so success or failure in this area can drive steady revenue or costly setbacks—think of it as a niche, high‑safety consumer product line for vision health.

3pl technical

"providing both non-title and 3PL title distribution services"

A 3PL, or third-party logistics provider, is an outside company hired to handle warehousing, transportation, order fulfillment and related supply-chain tasks that a business chooses not to run itself. Investors care because outsourcing these functions can reduce costs, speed delivery, and allow a company to scale or enter new markets quickly, but it also creates dependency and operational risk that can affect profit margins and reliability.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

OLIVE BRANCH, Miss., April 14, 2026 /PRNewswire/ -- LogiCare3PL today announced it has been selected by Harrow, Inc. (Nasdaq: HROW) as a distribution partner for Harrow's portfolio of ophthalmic disease management solutions. Effective February 1, 2026, LogiCare3PL is providing both non-title and 3PL title distribution services, supporting distribution of Harrow's products across the U.S. market.

LogiCare3PL was selected for its high-touch service model, proven ability to execute quickly and efficiently, and commitment to building a long-term partnership. These capabilities were essential in supporting Harrow's need for rapid onboarding and market readiness.

This partnership enables faster, more cost-effective market access for Harrow's products, while maintaining a high level of engagement and support from the LogiCare3PL team. LogiCare3PL successfully onboarded Harrow within just four weeks, meeting Harrow's implementation timeline and ensuring business continuity.

Kevin Kissling, VP/GM 3PL Services for LogiCare3PL, commented: "We are proud to partner with Harrow and support their broad portfolio of ophthalmic disease management solutions. At LogiCare3PL, we are committed to delivering on every promise we make and developing solutions that meet each manufacturer's specific needs. Harrow and LogiCare3PL's shared focus on flexibility, customer-centricity, and rapid execution makes this collaboration especially meaningful."

The agreement, effective February 1, 2026, covers LogiCare3PL's full suite of 3PL services, including non-title logistics support and title distribution for Harrow's products. Both organizations anticipate continued collaboration as Harrow expands its product offerings.

About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com and connect with us on LinkedIn.

About LogiCare3PL
LogiCare3PL, a BioCare company, is a trusted pharmaceutical third‑party logistics partner serving emerging and mid‑sized biopharmaceutical manufacturers. Specializing in specialty, rare, and ultra‑rare disease therapies, LogiCare3PL delivers tailored, end‑to‑end solutions including time‑ and temperature‑sensitive logistics, centralized warehousing, financial services, regulatory compliance and licensing support, advanced data analytics, and comprehensive manufacturer and customer care. Through an integrated, compliant, and reliable approach, LogiCare3PL ensures products move securely from manufacturer to market. With unmatched reliability and expertise, LogiCare3PL sets the standard for precision and trust in pharmaceutical logistics.

Media Contact:
BioCare, Inc.

Barbara Pantazopoulos
VP Marketing & Communications
barbara.pantazopoulos@biocaresd.com
biocare-us.com  

View original content to download multimedia:https://www.prnewswire.com/news-releases/logicare3pl-selected-as-distribution-partner-by-harrow-302741856.html

SOURCE LogiCare3PL

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What distribution services will LogiCare3PL provide for Harrow (HROW)?

LogiCare3PL will supply both non-title logistics and 3PL title distribution for Harrow. According to LogiCare3PL, the agreement covers the company's full suite of 3PL services to support Harrow's ophthalmic portfolio across the U.S.

When did the LogiCare3PL and Harrow (HROW) distribution agreement become effective?

The distribution agreement became effective on Feb 1, 2026. According to Harrow, operations under the partnership began then, with LogiCare3PL completing onboarding within the prescribed implementation timeline.

How quickly did LogiCare3PL onboard Harrow (HROW) products for distribution?

LogiCare3PL completed Harrow onboarding in four weeks, meeting the company's timeline. According to LogiCare3PL, this rapid onboarding ensured business continuity and faster market readiness for Harrow's products.

What geographic market will LogiCare3PL cover for Harrow (HROW)?

LogiCare3PL will support distribution across the U.S. market for Harrow's ophthalmic solutions. According to Harrow, the partnership is intended to enable faster, more cost-effective nationwide market access.

Why did Harrow (HROW) select LogiCare3PL as its distribution partner?

Harrow selected LogiCare3PL for its high-touch service model and rapid execution. According to Harrow, LogiCare3PL's ability to onboard quickly and deliver sustained engagement were key selection factors.

What operational impact does the LogiCare3PL partnership have on Harrow (HROW) product access?

The partnership is expected to enable faster and more cost-effective market access while preserving service levels. According to Harrow, LogiCare3PL's engagement model and logistics capabilities support ongoing expansion of Harrow's product offerings.